Bioprosthetic aortic valve replacement in patients aged 50 years old and younger: Structural valve deterioration at long-term follow-up. Retrospective study.
AVR, Aortic Valve Replacement
Aortic valve replacement
Bioprosthesis
EF, Ejection Fraction
LV, Left Ventricle
NYHA, New York Heart Association
PASP, Pulmonary Artery Systolic Pressure
PPM, Prosthesis-Patient Mismatch
Reoperation
SVD, Structural Valve Deterioration
Structural valve deterioration
TAVR, Transcatheter Aortic Valve Replacement
TTE, Transthoracic Echocardiography
bAVR, bioprosthetic Aortic Valve Replacement
Journal
Annals of medicine and surgery (2012)
ISSN: 2049-0801
Titre abrégé: Ann Med Surg (Lond)
Pays: England
ID NLM: 101616869
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
received:
16
03
2022
revised:
10
04
2022
accepted:
10
04
2022
entrez:
31
5
2022
pubmed:
1
6
2022
medline:
1
6
2022
Statut:
epublish
Résumé
Structural valve deterioration (SVD) remains the major determinant of bioprosthesis durability. The aim of this study was to investigate the SVD incidence, predictors and outcomes in patients aged 50 years and younger after bioprosthetic aortic valve replacement (bAVR). We retrospectively analyzed 73 consecutive patients ≤50 years old who underwent bioprosthetic AVR at our center between 2005 and 2015. Median age at surgery was 44 (interquartile range [IQR]: 39-47) years. Follow-up was 93.2% complete at a median time of 7.2 (IQR: 5.5-9.5) years. Cumulative follow-up was 545.5 valve-years. Bioprosthesis SVD was determined by strict echocardiographic assessment. The overall survival-rate at 10/15 years and freedom from SVD at 10/12.5 years were 89.6 ± 5.2%/81.5 ± 9.1% and 73.5 ± 8.2%/41.9 ± 18.9%, respectively. SVD occurred at a median time of 8.2 (IQR: 6.0-9.9) years after bAVR. Age was not found as an independent predictor for SVD at the multivariable model, despite a higher rate of SVD in the age group ≤30 years. Freedom from reoperation due to SVD at 10/15 years was 71.3 ± 14.1%/13.6 ± 12.3%. Reoperation was performed at a median time of 10.0 (IQR: 8.9-11.9) years since first bAVR and was associated with a 100% 12-month survival. In our study, the rate and time of SVD occurrence were comparable to those of other studies' older age groups. Strict echocardiographic monitoring of valve performance is mandatory to set the appropriate timing of eventual reoperation. This attitude can improve outcomes of bAVR in younger patients.
Sections du résumé
Background
UNASSIGNED
Structural valve deterioration (SVD) remains the major determinant of bioprosthesis durability. The aim of this study was to investigate the SVD incidence, predictors and outcomes in patients aged 50 years and younger after bioprosthetic aortic valve replacement (bAVR).
Methods
UNASSIGNED
We retrospectively analyzed 73 consecutive patients ≤50 years old who underwent bioprosthetic AVR at our center between 2005 and 2015. Median age at surgery was 44 (interquartile range [IQR]: 39-47) years. Follow-up was 93.2% complete at a median time of 7.2 (IQR: 5.5-9.5) years. Cumulative follow-up was 545.5 valve-years. Bioprosthesis SVD was determined by strict echocardiographic assessment.
Results
UNASSIGNED
The overall survival-rate at 10/15 years and freedom from SVD at 10/12.5 years were 89.6 ± 5.2%/81.5 ± 9.1% and 73.5 ± 8.2%/41.9 ± 18.9%, respectively. SVD occurred at a median time of 8.2 (IQR: 6.0-9.9) years after bAVR. Age was not found as an independent predictor for SVD at the multivariable model, despite a higher rate of SVD in the age group ≤30 years. Freedom from reoperation due to SVD at 10/15 years was 71.3 ± 14.1%/13.6 ± 12.3%. Reoperation was performed at a median time of 10.0 (IQR: 8.9-11.9) years since first bAVR and was associated with a 100% 12-month survival.
Conclusions
UNASSIGNED
In our study, the rate and time of SVD occurrence were comparable to those of other studies' older age groups. Strict echocardiographic monitoring of valve performance is mandatory to set the appropriate timing of eventual reoperation. This attitude can improve outcomes of bAVR in younger patients.
Identifiants
pubmed: 35637981
doi: 10.1016/j.amsu.2022.103624
pii: S2049-0801(22)00384-3
pmc: PMC9142659
doi:
Types de publication
Journal Article
Langues
eng
Pagination
103624Informations de copyright
© 2022 The Authors.
Déclaration de conflit d'intérêts
None.
Références
Ann Thorac Surg. 2015 Sep;100(3):853-9
pubmed: 26187006
Eur J Cardiothorac Surg. 2015 Jan;47(1):159-67; discussion 167
pubmed: 24574445
J Thorac Cardiovasc Surg. 2012 Nov;144(5):1075-83
pubmed: 22341653
J Am Coll Cardiol. 2017 May 9;69(18):2253-2262
pubmed: 28473128
J Thorac Cardiovasc Surg. 2008 Apr;135(4):732-8
pubmed: 18374749
J Am Coll Cardiol. 2018 Jul 17;72(3):241-251
pubmed: 30012316
JACC Cardiovasc Imaging. 2020 Feb;13(2 Pt 1):345-353
pubmed: 30878425
J Thorac Cardiovasc Surg. 2009 Jan;137(1):82-90
pubmed: 19154908
Heart Surg Forum. 2015 Aug 30;18(4):E129-33
pubmed: 26334847
J Thorac Cardiovasc Surg. 2014 Nov;148(5):1931-9
pubmed: 24521965
J Thorac Cardiovasc Surg. 2018 Feb;155(2):539-547.e9
pubmed: 29110948
J Am Coll Cardiol. 2017 Jul 11;70(2):252-289
pubmed: 28315732
J Am Coll Cardiol. 2020 Oct 20;76(16):1830-1843
pubmed: 33059828
Ann Thorac Surg. 2014 May;97(5):1526-32
pubmed: 24681031
J Thorac Cardiovasc Surg. 2018 Jun;155(6):2379-2387
pubmed: 29567131
Ann Thorac Surg. 2010 Oct;90(4):1195-200; discussion 1201
pubmed: 20868814
J Am Coll Cardiol. 2013 Feb 19;61(7):752-61
pubmed: 23410546
Circulation. 2009 Feb 24;119(7):1034-48
pubmed: 19237674
Circulation. 2007 Sep 11;116(11 Suppl):I294-300
pubmed: 17846320
Ann Thorac Surg. 2011 Apr;91(4):1120-6
pubmed: 21276956
Ann Thorac Surg. 2014 Feb;97(2):537-43
pubmed: 24036070
Ann Thorac Surg. 2001 Sep;72(3):753-7
pubmed: 11565653
Ann Thorac Surg. 2015 Apr;99(4):1239-47
pubmed: 25662439
Ann Thorac Surg. 2016 Dec;102(6):1956-1965
pubmed: 27544291
J Thorac Cardiovasc Surg. 2009 Apr;137(4):881-6, 886e1-5
pubmed: 19327512
Int J Surg. 2021 Dec;96:106165
pubmed: 34774726
Eur Heart J Cardiovasc Imaging. 2016 Jun;17(6):589-90
pubmed: 27143783
Eur J Cardiothorac Surg. 2003 Dec;24(6):873-8
pubmed: 14643803
Circulation. 2018 Jan 23;137(4):388-399
pubmed: 29358344
Circulation. 2010 May 18;121(19):2123-9
pubmed: 20439787
J Thorac Cardiovasc Surg. 2008 Sep;136(3):688-96
pubmed: 18805273
Nat Rev Cardiol. 2010 Dec;7(12):711-9
pubmed: 21045786